COVID-19 vaccine tracker and landscape

Number COVID-19 vaccines

COVID-19 vaccine tracker and landscape

The COVID-19 vaccine tracker and landscape compiles detailed information of each COVID-19 vaccine candidate in development by closely monitoring their progress through the pipeline.

The COVID-19 vaccine tracker:

  • Provides summary tables of COVID-19 vaccine candidates in both clinical and pre-clinical development;
  • Provides analysis and visualization for several COVID-19 vaccine candidate categories;
  • Tracks the progress of each vaccine from pre-clinical, Phase 1, Phase 2 through to Phase 3 efficacy studies and including Phase 4 registered as interventional studies;
  • Provides links to published reports on safety, immunogenicity and efficacy data of the vaccine candidates;
  • Includes information on key attributes of each vaccine candidate and
  • Allows users to search for COVID-19 vaccines through various criteria such as vaccine platform, schedule of vaccination, route of administration, developer, trial phase and clinical endpoints.

The database is updated regularly - twice a week (Tuesday and Friday, 17:00 CET)

 

Submission of data

All data from independent institutions and vaccine developers are welcome to provide information on vaccine candidates being developed using the information template. Submitted data will be made openly accessible on a regular basis to enable fast data sharing.

 

Data extraction tools and sources

To ensure the latest information is available, the landscape will be updated twice a week (Tuesday and Friday, 17:00 CET) by searching, gathering and cross-checking data from multiple sources such as the Cochrane vaccine mapping tool, PubMed, ClinicalTrials.gov, WHO ICTRP and from a network of researchers and industry for new candidate vaccines by screening registered trials for clinical information.  Where data is missing, we either do not add any information (blank cells) or we supplement information gathered from press or public releases.  We welcome your feedback to help us update or make necessary changes, please note any updates will only be done twice a week.

 

Contact us

The R&D Blueprint team is responsible for developing the COVID-19 candidate vaccine landscape database. For questions relating to the collection or sharing of data for novel COVID-19 vaccine candidates, please contact us at: rdblueprint@who.int

 

News

6 – 8 November 2023

Join the global effort to enhance access to health technologies: second World Local Production Forum to be held in the Kingdom of the Netherlands in 2023
10 May 2023 14:30 – 15:30 CET

Promoting the health of refugees and migrants: experiences from around the world
2 – 3 May 2023

Global stocktake of COVID-19 vaccine delivery
13 – 15 March 2023

Global Convening on COVID-19 Vaccination Monitoring and Related System Strengthening
14 February 2023 08:30 – 17:30 EAT

Joint Convening on COVID-19 Vaccinations in Humanitarian settings and contribution to broader pandemic preparedness
28 October 2022 13:00 – 15:30 CET

12th ACT-Accelerator Facilitation Council meeting
6 July 2022 12:30 – 15:00 CET

11th ACT-Accelerator Facilitation Council meeting
17 May 2022 14:00 – 16:00 CET

Follow-up Meeting: A WHO Strategic Agenda for Filovirus Research and Monitoring (AFIRM)
30 March 2022 14:00 – 19:20 CET

A WHO Strategic Agenda for Filovirus Research and Monitoring (AFIRM) - Roadmap Meeting
25 March 2022 13:00 – 18:30 CET

WHO consultation on COVID-19 vaccines research - Advancing the development of pan-sarbecovirus vaccines
24 – 25 February 2022

COVID-19 Research and Innovation: Powering the world’s pandemic response – now and in the future.
23 February 2022 13:00 – 19:30 CET

Developing a framework for evaluating new COVID-19 vaccines
18 February 2022

mRNA vaccine technology transfer spokes launch event
14 February 2022 13:00 – 17:15 CET

What recent evidence do we have that omicron is evading immunity and what are the implications?
9 February 2022 15:00 – 16:00 CET

ACT-Accelerator campaign launch
28 January 2022 13:00 – 19:00 CET

WHO consultation on COVID vaccines research: Why do we need a pan-sarbecovirus vaccine?
15 December 2021 14:30 – 17:30 CET

WHO Global Consultation - What evidence do we have that omicron is evading immunity and what are the implications?
6 December 2021 13:00 – 19:00 CET

WHO consultation on COVID-19 vaccines research:  How can vaccine research further contribute to achieve the control of the pandemic everywhere?
25 October 2021 13:00 – 18:00 CET

WHO consultation on COVID-19 vaccines research:  Emerging evidence on safety and the need for additional doses of COVID-19 vaccines
4 – 8 October 2021

Strategic Advisory Group of Experts on Immunization (SAGE) - October 2021